|
Test Catalog
|
|
GLUD1 (CH) DNA Sequencing Test |
#822 |
|
| Type of Disorder: |
Congenital Hyperinsulinism |
|
| Typical Presentation: |
Severe, persistent hypoglycemia in newborns |
|
| Indications for Testing: |
Severe, persistent hypoglycemia in newborns or infants
Family member with an identified mutation in GLUD1 |
|
| Test Details |
|
| Test Code: |
822 |
|
| Profiles that contain this test: |
Congenital Hyperinsulinism Evaluation
|
|
| Informed Consent Required: |
Yes |
|
| Medicare ABN Required: |
Yes |
|
| Special Notes: |
N/A |
|
| Technical Information |
|
| Utility: |
Detects mutations (including point mutations, deletions, insertions, and rearrangements) in the coding sequences of GLUD1 |
|
| Methodology: |
Polymerase Chain Reaction (PCR), DNA sequencing of entire protein coding region of gene |
|
| Reference Value: |
No mutation detected |
|
| CPT Code(s): |
83891(1), 83898(14), 83904(14), 83909(1), 83912(1) |
|
| Patents: |
N/A |
|
| Shipping Considerations |
|
| Preferred Specimen Requirements |
| Type: |
Whole blood |
| Minimum Volume: |
10 ml (pediatric minimum: 2mL) |
| Collection Tube: |
Yellow or lavender top |
| Stability: |
Hemolysis may compromise DNA recovery after 48 hrs |
|
| Storage Conditions: |
For short periods (until shipped) at 4oC |
|
| Shipping Conditions: |
Overnight at room temperature (specimen arrival must be less than 24 hrs after collection); Ship Monday through Thursday only |
|
| Test Turnaround: |
2 - 8 weeks |
|
|
|
